Randomized, Phase II study of pemetrexed plus bevacizumab versus pemetrexed alone after treatment with cisplatin, pemetrexed, and bevacizumab in advanced non‐squamous, non‐small cell lung cancer: TORG (thoracic oncology research group) 1321

INTRODUCTION: Cisplatin plus pemetrexed followed by pemetrexed is an efficacious platinum combination regimen for advanced non‐squamous, non‐small cell lung cancer (NSCLC). Data regarding the addition of bevacizumab, especially in maintenance treatment, are insufficient. METHODS: Eligibility criteri...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasai, Takashi, Mori, Kiyoshi, Nakamura, Yoichi, Seki, Nobuhiko, Ichikawa, Yasuko, Saito, Haruhiro, Kondo, Tetsuro, Nishikawa, Kazuo, Otsu, Satoshi, Bessho, Akihiro, Tanaka, Hiroshi, Yamaguchi, Hiroyuki, Kaburagi, Takayuki, Imai, Hisao, Mori, Keita, Ohtake, Junya, Okamoto, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417045/
https://www.ncbi.nlm.nih.gov/pubmed/37226421
http://dx.doi.org/10.1002/cam4.6135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417045/
https://www.ncbi.nlm.nih.gov/pubmed/37226421
http://dx.doi.org/10.1002/cam4.6135

Ejemplares similares